phenobarbital has been researched along with kanamycin a in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chow-Tung, E; John, EG; Lau, AH; Vidyasagar, D | 1 |
| Berk, PD; Blaschke, TF; Guyther, JR; Scharschmidt, BF; Vergalla, JM; Waggoner, JG | 1 |
| Shaywitz, BA | 1 |
1 review(s) available for phenobarbital and kanamycin a
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 other study(ies) available for phenobarbital and kanamycin a
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Effect of peritoneal dialysis on serum concentrations of three drugs commonly used in pediatric patients.
Topics: Amikacin; Cefazolin; Female; Humans; Infant; Infant, Newborn; Kanamycin; Male; Metabolic Clearance Rate; Peritoneal Dialysis; Phenobarbital | 1985 |
Crigler-Najjar syndrome: an unusual course with development of neurologic damage at age eighteen.
Topics: Adolescent; Alkaline Phosphatase; Bilirubin; Brain Damage, Chronic; Brain Diseases; Carbon Monoxide; Erythrocyte Aging; Female; Glucuronates; Glutethimide; Humans; Hyperbilirubinemia, Hereditary; Indocyanine Green; Kanamycin; Liver Function Tests; Phenobarbital; Phenytoin; Phototherapy; Plasmapheresis; Protein Binding; Radioisotopes; Renal Dialysis; Salicylamides; Sulfobromophthalein; Syndrome; Transaminases | 1974 |
Extreme elevations of cerebrospinal fluid protein. Association with hypernatremic dehydration.
Topics: Blood Proteins; Blood-Brain Barrier; Central Nervous System Diseases; Cerebrospinal Fluid Proteins; Dehydration; Diarrhea; Female; Humans; Hypernatremia; Infant; Kanamycin; Lumbosacral Region; Male; Penicillins; Phenobarbital; Phenytoin; Seizures; Sodium Chloride; Spinal Puncture | 1970 |